Usp7 controls chk1 protein stability by direct deubiquitination

Cell Cycle

Volumn 13, Issue 24, 2014, Pages 3921-3926

  Vega, Ignacio Alonso De ^a   Martín, Yusé ^a   Smits, Veronique A J ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Chk1; Claspin; Ubiquitin hydrolase; USP7

Indexed keywords

CHECKPOINT KINASE 1; HYDROLASE; UBIQUITIN; UNCLASSIFIED DRUG; USP7 PROTEIN; ATM PROTEIN; CLSPN PROTEIN, HUMAN; MDM2 PROTEIN, HUMAN; PROTEIN KINASE; PROTEIN MDM2; PROTEIN P53; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN;

ARTICLE; DNA DAMAGE; ENZYME REGULATION; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; PROTEIN DEPLETION; PROTEIN STABILITY; UBIQUITINATION; WILD TYPE; ANTAGONISTS AND INHIBITORS; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; PROTEIN KINASES; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 84920621864     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.973324     Document Type: Article

References (27)

1. Bartek J, Bartkova J, Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007; 26:7773-9; PMID: 18066090; http://dx.doi.org/10.1038/sj.onc.1210881
2. Smits VAJ, Warmerdam DO, Martín Y, Freire R. Mechanisms of ATR-mediated checkpoint signalling. Front Biosci 2010; 15:840-53; http://dx.doi.org/ 10.2741/3649
3. Smith J, Tho LM, Xu N, Gillespie DA. The ATMChk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 2010; 108:73-112; PMID:21034966; http://dx.doi.org/10.1016/B978-0-12-380888-2.00003-0
4. Smits VAJ, Reaper PM, Jackson SP. Rapid PIKKdependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr Biol 2006; 16:150-9; PMID:16360315; http://dx.doi.org/ 10.1016/j.cub.2005.11.066
5. Smits VAJ. Spreading the signal: dissociation of Chk1 from chromatin. Cell Cycle 2006; 5:1039-43; PMID: 16721053; http://dx.doi.org/10.4161/cc.5.10.2761
6. Zhang Y-W, Otterness DM, Chiang GG, Xie W, Liu Y-C, Mercurio F, Abraham RT. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol Cell 2005; 19:607-18; PMID:16137618; http://dx.doi.org/10.1016/j. molcel.2005.07.019
7. Zhang Y-W, Brognard J, Coughlin C, You Z, Dolled-Filhart M, Aslanian A, Manning G, Abraham RT, Hunter T. The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress. Mol Cell 2009; 35:442-53; PMID:19716789; http://dx.doi. org/10.1016/j.molcel.2009.06.030
8. Hussain S, Zhang Y, Galardy PJ. DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, nononcogenes and tumor suppressors. Cell Cycle 2009; 8:1688-97; PMID:19448430; http://dx.doi.org/ 10.4161/cc.8.11.8739
9. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 2002; 416:648-53; PMID:11923872; http://dx.doi.org/ 10.1038/nature737
10. Hu M, Gu L, Li M, Jeffrey PD, Gu W, Shi Y. Structural basis of competitive recognition of p53 and MDM2 by HAUSPUSP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol 2006; 4: e27; PMID:16402859; http://dx.doi.org/10.1371/ journal.pbio.0040027
11. Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J, Pandolfi PP. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 2008; 455:813-7; PMID:18716620; http://dx.doi.org/10.1038/ nature07290
12. van der Horst A, de Vries-Smits AMM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM, Burgering BMT. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7HAUSP. Nat Cell Biol 2006; 8:1064-73; PMID:16964248; http://dx.doi.org/10.1038/ncb1469
13. Faustrup H, Bekker-Jensen S, Bartek J, Lukas J, Mailand N. USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin. J Cell Biol 2009; 184:13-9; PMID:19124652; http://dx.doi.org/ 10.1083/jcb.200807137
14. Martín Y, Cabrera E, Amoedo H, Hern-andez-P-erez S, Domínguez-Kelly R, Freire R. USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination. Oncogene 2014 Mar 17; [Epub ahead of print]; PMID: 24632611; http://dx.doi.org/10.1038/onc.2014.38
15. Kaneko YS, Watanabe N, Morisaki H, Akita H, Fujimoto A, Tominaga K, Terasawa M, Tachibana A, Ikeda K, Nakanishi M, et al. Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene 1999; 18:3673-81; PMID:10391675; http://dx.doi.org/10.1038/sj.onc.1202706
16. Altun M, Kramer HB, Willems LI, McDermott JL, Leach CA, Goldenberg SJ, Kumar KGS, Konietzny R, Fischer R, Kogan E, et al. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chem Biol 2011; 18:1401-12; PMID:22118674; http://dx.doi.org/10.1016/j. chembiol.2011.08.018
17. Chini CCS, Wood J, Chen J. Chk1 is required to maintain claspin stability. Oncogene 2006; 25:4165-71; PMID:16501606; http://dx.doi.org/10.1038/sj. onc.1209447
18. Lin Y-F, Shih H-Y, Shang Z, Matsunaga S, Chen BP. DNA-PKcs is required to maintain stability of Chk1 and Claspin for optimal replication stress response. Nucleic Acids Res 2014; 42:4463-73; PMID: 24500207; http://dx.doi.org/10.1093/nar/gku116
19. Freire R, van Vugt MATM, Mamely I, Medema RH. Claspin: timing the cell cycle arrest when the genome is damaged. Cell Cycle 2006; 5:2831-4; PMID: 17172868; http://dx.doi.org/10.4161/cc.5.24.3559
20. Sørensen CS, Syljua Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage. Cell Cycle 2004; 3:941-5; PMID:15190204
21. Nicholson B, Suresh Kumar KG. The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem Biophys 2011; 60:61-8; PMID:21468693; http://dx.doi.org/10.1007/s12013-011-9185-5
22. Huang TT, Nijman SMB, Mirchandani KD, Galardy PJ, Cohn MA, Haas W, Gygi SP, Ploegh HL, Bernards R, D'Andrea AD. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol 2006; 8:339-47; PMID:16531995
23. Mei Y, Hahn AA, Hu S, Yang X. The USP19 Deubiquitinase Regulates the Stability of c-IAP1 and c-IAP2. J Biol Chem 2011; 286:35380-7; PMID:21849505; http://dx.doi.org/10.1074/jbc.M111.282020
24. Meray RK, Lansbury PT. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J Biol Chem 2007; 282:10567-75; PMID:17259170; http://dx.doi.org/ 10.1074/jbc.M611153200
25. Shen C. CalciumCalmodulin Regulates Ubiquitination of the Ubiquitin-specific Protease TRE17USP6. J Biol Chem 2005; 280:35967-73; PMID:16127172; http:// dx.doi.org/10.1074/jbc.M505220200
26. Mamely I, van Vugt MA, Smits VAJ, Semple JI, Lemmens B, Perrakis A, Medema RH, Freire R. Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Curr Biol 2006; 16:1950-5; PMID:16934469; http://dx.doi.org/ 10.1016/j.cub.2006.08.026
27. Semple JI, Smits VAJ, Fernaud J-R, Mamely I, Freire R. Cleavage and degradation of Claspin during apoptosis by caspases and the proteasome. Cell Death Differ 2007; 14:1433-42; PMID:17431426; http://dx.doi. org/10.1038/sj.cdd.4402134